{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:07:35Z","timestamp":1784203655597,"version":"3.55.0"},"reference-count":17,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Pharmacy Therapeu"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1111\/jcpt.13789","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T05:45:08Z","timestamp":1667454308000},"page":"2182-2187","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The effect of changing to Bictegravir on lipids using real world data: A brief report"],"prefix":"10.1155","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-3433","authenticated-orcid":false,"given":"Thomas","family":"Heseltine","sequence":"first","affiliation":[{"name":"Department of Cardiology Royal Liverpool University Hospital  Liverpool UK"},{"name":"Institute of Translational Medicine University of Liverpool  Liverpool UK"},{"name":"Liverpool Centre for Cardiovascular Science University of Liverpool and Liverpool Heart & Chest Hospital  Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elen","family":"Hughes","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science University of Liverpool and Liverpool Heart & Chest Hospital  Liverpool UK"},{"name":"Wirral University Teaching Hospital  Wirral UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Cardiology Royal Liverpool University Hospital  Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Murray","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science University of Liverpool and Liverpool Heart & Chest Hospital  Liverpool UK"},{"name":"Wirral University Teaching Hospital  Wirral UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saye","family":"Khoo","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine University of Liverpool  Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7954"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(16)30020-2"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.3728"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(15)00056\u20100"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002069"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062744"},{"issue":"10107","key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(17)32340-1","article-title":"Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV\u20101 infection (GS\u2010US\u2010380\u20131490): a randomised, double\u2010blind, multicentre, phase 3, non\u2010inferiority trial","volume":"390","author":"Sax PE","year":"2017","journal-title":"Lancet"},{"key":"e_1_2_8_9_1","first-page":"12","article-title":"Three\u2010year outcomes of the fixed\u2010dose combination bictegravir, emtricitabine, and tenofovir alafenamide vs dolutegravir\u2010containing regimens for initial treatment of HIV\u20101 infection: week 144 results from two randomised, double\u2010blind, multicentre, phase 3","volume":"7","author":"Rofifah D","year":"2020","journal-title":"Pap Knowl Towar a Media Hist Doc"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30091-2"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103018(19)30077\u20103"},{"issue":"6","key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1016\/S2352-3018(19)30080-3","article-title":"Co\u2010formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV\u20101 infection: week 96 results from a randomised, double\u2010blind, multicentre, phase 3, non\u2010inferiority trial","volume":"6","author":"Stellbrink HJ","year":"2019","journal-title":"Lancet HIV"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa988"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S274307"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879\u2010021\u201006479\u20109"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1518"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027330"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30043-2"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13789","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcpt.13789","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.13789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:55Z","timestamp":1671818695000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.13789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1111\/jcpt.13789"],"URL":"https:\/\/doi.org\/10.1111\/jcpt.13789","archive":["Portico"],"relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"2021-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}